Obesity modulates the cellular and molecular microenvironment in the peritoneal cavity: implication for ovarian cancer risk

被引:3
作者
Shea, Amanda A. [1 ]
Heffron, Connie Lynn [2 ]
Grieco, Joseph P. [3 ]
Roberts, Paul C. [2 ]
Schmelz, Eva M. [1 ]
机构
[1] Dept Human Nutr Foods & Exercise, Virginia Tech, Blacksburg, VA 24061 USA
[2] Virginia Tech, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA
[3] Grad Program Translat Biol Med & Hlth, Virginia Tech, Blacksburg, VA USA
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 14卷
基金
美国食品与农业研究所;
关键词
obesity; ovarian cancer; inflammation; B cells; MDSCs; ascites; adhesion; tumor microenvironment; BODY-MASS INDEX; ADIPOSE-TISSUE; TUMOR PROGRESSION; HIGH-FAT; B-CELLS; SURVIVAL; ASCITES; MACROPHAGES; METASTASIS; CARCINOMA;
D O I
10.3389/fimmu.2023.1323399
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IntroductionAbdominal obesity increases the risk of developing ovarian cancer but the molecular mechanisms of how obesity supports ovarian cancer development remain unknown. Here we investigated the impact of obesity on the immune cell and gene expression profiles of distinct abdominal tissues, focusing on the peritoneal serous fluid (PSF) and the omental fat band (OFB) as critical determinants for the dissemination of ovarian metastases and early metastatic events within the peritoneal cavity.MethodsFemale C57BL/6 mice were fed a low-fat (LFD) or a high-fat diet (HFD) for 12 weeks until the body weights in the HFD group were significantly higher and the mice displayed an impaired glucose tolerance. Then the mice were injected with the murine ovarian cancer cells (MOSE-LTICv) while remaining on their diets. After 21 days, the mice were sacrificed, tumor burden was evaluated and tissues were harvested. The immune cell composition of abdominal tissues and changes in gene expression in the PSF and OFB were evaluated by flow cytometry and qPCR RT2-profiler PCR arrays and confirmed by qRT-PCR, respectively. Other peritoneal adipose tissues including parametrial and retroperitoneal white adipose tissues as well as blood were also investigated.ResultsWhile limited effects were observed in the other peritoneal adipose tissues, feeding mice the HFD led to distinct changes in the immune cell composition in the PSF and the OFB: a depletion of B cells but an increase in myeloid-derived suppressor cells (MDSC) and mono/granulocytes, generating pro-inflammatory environments with increased expression of cyto- and chemokines, and genes supporting adhesion, survival, and growth, as well as suppression of apoptosis. This was associated with a higher peritoneal tumor burden compared to mice fed a LFD. Changes in cellular and genetic profiles were often exacerbated by the HFD. There was a large overlap in genes that were modulated by both the HFD and the cancer cells, suggesting that this 'genetic fingerprint' is important for ovarian metastases to the OFB.DiscussionIn accordance with the 'seed and soil' theory, our studies show that obesity contributes to the generation of a pro-inflammatory peritoneal environment that supports the survival of disseminating ovarian cancer cells in the PSF and the OFB and enhances the early metastatic adhesion events in the OFB through an increase in extracellular matrix proteins and modulators such as fibronectin 1 and collagen I expression as well as in genes supporting growth and invasion such as Tenacin C. The identified genes could potentially be used as targets for prevention strategies to lower the ovarian cancer risk in women with obesity.
引用
收藏
页数:19
相关论文
共 83 条
  • [1] The Synergy between Palmitate and TNF-α for CCL2 Production Is Dependent on the TRIF/IRF3 Pathway: Implications for Metabolic Inflammation
    Ahmad, Rasheed
    Al-Roub, Areej
    Kochumon, Shihab
    Akther, Nadeem
    Thomas, Reeby
    Kumari, Manju
    Koshy, Merin S.
    Tiss, Ali
    Hannun, Yusuf A.
    Tuomilehto, Jaakko
    Sindhu, Sardar
    Rosen, Evan D.
    [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (10) : 3599 - 3611
  • [2] Metabolic changes during ovarian cancer progression as targets for sphingosine treatment
    Anderson, Angela S.
    Roberts, Paul C.
    Frisard, Madlyn I.
    McMillan, Ryan P.
    Brown, Timothy J.
    Lawless, Michael H.
    Hulver, Matthew W.
    Schmelz, Eva M.
    [J]. EXPERIMENTAL CELL RESEARCH, 2013, 319 (10) : 1431 - 1442
  • [3] Central body fatness is a stronger predictor of cancer risk than overall body size
    Barberio, Amanda M.
    Alareeki, Asalah
    Viner, Benjamin
    Pader, Joy
    Vena, Jennifer E.
    Arora, Paul
    Friedenreich, Christine M.
    Brenner, Darren R.
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [4] Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion
    Barbolina, Maria V.
    Adley, Brian P.
    Kelly, David L.
    Shepard, Jaclyn
    Fought, Angela J.
    Scholtens, Denise
    Penzes, Peter
    Shea, Lonnie D.
    Stack, M. Sharon
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (04) : 816 - 825
  • [5] Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies
    Beral, V.
    Hermon, C.
    Peto, R.
    Reeves, G.
    Brinton, L.
    Marchbanks, P.
    Negri, E.
    Ness, R.
    Peeters, P. H. M.
    Vessey, M.
    Calle, E. E.
    Gapstur, S. M.
    Patel, A. V.
    Dal Maso, L.
    Talamini, R.
    Chetrit, A.
    Hirsh-Yechezkel, G.
    Lubin, F.
    Sadetzki, S.
    Allen, N.
    Bull, D.
    Callaghan, K.
    Crossley, B.
    Gaitskell, K.
    Goodill, A.
    Green, J.
    Key, T.
    Moser, K.
    Collins, R.
    Doll, R.
    Gonzalez, C. A.
    Lee, N.
    Ory, H. W.
    Peterson, H. B.
    Wingo, P. A.
    Martin, N.
    Pardthaisong, T.
    Silpisornkosol, S.
    Theetranont, C.
    Boosiri, B.
    Chutivongse, S.
    Jimakorn, P.
    Virutamasen, P.
    Wongsrichanalai, C.
    Tjonneland, A.
    Titus-Ernstoff, L.
    Byers, T.
    Rohan, T.
    Mosgaard, B. J.
    Yeates, D.
    [J]. PLOS MEDICINE, 2012, 9 (04)
  • [6] Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
    Bronte, Vincenzo
    Brandau, Sven
    Chen, Shu-Hsia
    Colombo, Mario P.
    Frey, Alan B.
    Greten, Tim F.
    Mandruzzato, Susanna
    Murray, Peter J.
    Ochoa, Augusto
    Ostrand-Rosenberg, Suzanne
    Rodriguez, Paulo C.
    Sica, Antonio
    Umansky, Viktor
    Vonderheide, Robert H.
    Gabrilovich, Dmitry I.
    [J]. NATURE COMMUNICATIONS, 2016, 7
  • [7] Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort
    Canchola, Alison J.
    Chang, Ellen T.
    Bernstein, Leslie
    Largent, Joan A.
    Reynolds, Peggy
    Deapen, Dennis
    Henderson, Katherine D.
    Ursin, Giske
    Horn-Ross, Pamela L.
    [J]. CANCER CAUSES & CONTROL, 2010, 21 (12) : 2241 - 2248
  • [8] Milky Spots Promote Ovarian Cancer Metastatic Colonization of Peritoneal Adipose in Experimental Models
    Clark, Robert
    Krishnan, Venkatesh
    Schoof, Michael
    Rodriguez, Irving
    Theriault, Betty
    Chekmareva, Marina
    Rinker-Schaeffert, Carrie
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2013, 183 (02) : 576 - 591
  • [9] Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells
    Clements, Virginia K.
    Long, Tiha
    Long, Ramses
    Figley, Chas
    Smith, Daniel M. C.
    Ostrand-Rosenberg, Suzanne
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2018, 103 (03) : 395 - 407
  • [10] Interleukin-12 Immunomodulation Delays the Onset of Lethal Peritoneal Disease of Ovarian Cancer
    Cohen, Courtney A.
    Shea, Amanda A.
    Heffron, C. Lynn
    Schmelz, Eva M.
    Roberts, Paul C.
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (01) : 62 - 73